Opaleye Management Inc.
Top Portfolio Positions
53 positions ·
$743,833,828 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| HROW |
Harrow, Inc.
Healthcare
|
2,832,230 | $99,864,429 | 13.43% | |
| LQDA |
Liquidia Corp
Healthcare
|
2,545,000 | $96,048,300 | 12.91% | |
| ETON |
Eton Pharmaceuticals, Inc.
Healthcare
|
2,860,000 | $70,584,800 | 9.49% | |
| SLGL |
Sol-Gel Technologies Ltd.
Healthcare
|
500,000 | $39,610,000 | 5.33% | |
| APGE |
Apogee Therapeutics, Inc.
Healthcare
|
390,000 | $32,826,300 | 4.41% | |
| IRON |
Disc Medicine, Inc.
Healthcare
|
421,000 | $26,918,740 | 3.62% | |
| URGN |
UroGen Pharma Ltd.
Healthcare
|
1,430,000 | $25,711,400 | 3.46% | |
| CBIO |
Crescent Biopharma, Inc.
Healthcare
|
1,312,615 | $24,112,737 | 3.24% | |
| STOK |
Stoke Therapeutics, Inc.
Healthcare
|
700,000 | $22,792,000 | 3.06% | |
| CATX |
Perspective Therapeutics, Inc.
Healthcare
|
4,675,000 | $19,494,750 | 2.62% |
Portfolio Trend
Holdings in ZNTL
Shares Held
Position Value (USD)
9 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,305,615 | 1,412,656 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,891,223 | 1,400,906 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $477,990 | 316,550 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,232,188 | 1,924,300 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $3,156,150 | 1,985,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $5,355,525 | 1,767,500 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,558,560 | 967,000 | Shares | Sole | 2024-11-14 | |
| 2024-03-31 | $3,152,000 | 200,000 | Shares | Sole | 2024-05-29 | |
| 2022-12-31 | $3,373,450 | 167,500 | Shares | Sole | 2023-02-10 | |
| No 13F history on record for this holder in this stock. | ||||||